What is Dry Eye Disease: Evolving Definitions and Epidemiology
2
Questionnaires Used to Assess Dry Eye Disease
3
Clinical Assessment of Dry Eye Disease: Tear Film and Ocular Surface Health
4
Clinical Assessment of Dry Eye Disease: Nerve Health
5
Pathophsiology of Dry Eye Disease using Animal Models
6
Pathophsiology of Dry Eye Disease using Human Models
Section 2: Dry Eye Disease (DED) in Specific Populations
7
Sjögrens and Dry Eye Disease
8
Graft versus Host and Dry Eye Disease
9
Meibomian Gland Dysfunction and Dry Eye Disease
10
Systemic Pain Conditions and Dry Eye Disease
11
Ocular Conditions and Dry Eye Disease
Section 3: Treatment of Dry Eye Disease (DEF)
12
Treatment of Dry Eye Disease in the United States
13
Treatment of Dry Eye Disease in Asia
14
Treatment of Dry Eye Disease in Europe
15
Treatment of Ocular Pain Not Responsive to Traditional Dry Eye Disease Treatments
Anat Galor is a staff physician at the Miami VAMC and a Professor of Ophthalmology at the Bascom Palmer Eye Institute, University of Miami. Dr. Galor received an undergraduate degree from Carnegie Mellon University in 1997 and a medical doctorate degree at Washington University School of Medicine in 2002. She pursued residency training in ophthalmology at the Cleveland Cole Eye Institute (2006) followed by fellowship training in uveitis at the Wilmer Eye Institute, Johns Hopkins University (2007) and fellowship training in cornea, external disease, and refractive surgery at the Bascom Palmer Eye Institute (2008).
Dr. Galor is the author of numerous publications that focus on dry eye, ocular surface tumors, and cornea. Dr. Galor's research has focused on understanding mechanisms of pain in dry eye, with an emphasis on studying new diagnostic and treatment modalities.
